Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 64 OF 86 | DISPLAYING 946 - 960 OF 1287 RESULTS

    Hu S. et al., Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes., [Epub ahead of print]., Sci. Reports, Apr 12, 2016

    Townsend E.C. et al., The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice., [Epub ahead of print]., Cancer Cell, Apr 11, 2016

    Romeo C. et al., HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Apr 06, 2016

    Parasramka M. et al., Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death., [Epub ahead of print]., European Urology Focus, Apr 02, 2016

    Spears M. et al., A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial., [Epub ahead of print]., Oncotarget, Apr 01, 2016

    Thompson E.M. et al., Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis., [Epub ahead of print]., The Lancet Oncology, Apr 01, 2016

    Wuerstlein R. et al., The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer., [Epub ahead of print]., Curr. Med. Res. Opin., Mar 30, 2016

    Griffiths O.L. et al., A genomic case study of mixed fibrolamellar hepatocellular carcinoma., [Epub ahead of print]., Annals Oncol., Mar 30, 2016

    Shen F. et al., Novel Small-molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells., [Epub ahead of print]., Mol. Can. Res., Mar 21, 2016

    Wuerstlein R. et. al., The WSG BCIST Study: A prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in ER-positive, HER2-negative early-stage breast cancer., [Epub ahead of print]., Curr. Med. Res. Opin., Mar 14, 2016

    Schmid P. et al., Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer, [Epub ahead of print]., J. Clin. Oncol., Mar 14, 2016

    Barry G.S. et al., Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC)., [Epub ahead of print]., Oncotarget, Mar 09, 2016

    Dadiani M. et al., Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy and Recurrence in Breast Cancer , [Epub ahead of print]., Clin. Can. Res., Mar 08, 2016

    D'Artista L. et al., Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc., [Epub ahead of print]., Oncotarget, Mar 02, 2016

    Zhou H. et al., Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism., [Epub ahead of print]., eLife, Feb 27, 2016